WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003061629) DNA DOSAGE FORMS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/061629    International Application No.:    PCT/GB2003/000336
Publication Date: 31.07.2003 International Filing Date: 23.01.2003
Chapter 2 Demand Filed:    04.08.2003    
IPC:
A61K 9/14 (2006.01), A61K 9/16 (2006.01), A61K 47/18 (2006.01), A61K 47/26 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (For All Designated States Except US).
CATCHPOLE, Ian, Richard [GB/GB]; (GB) (For US Only)
Inventors: CATCHPOLE, Ian, Richard; (GB)
Agent: EASEMAN, Richard, Lewis; GlaxoSmithKline, Corporate Intellectual Property (CN925.1), 980 Great West Road, Brentford, Middlesex TW8 9GS (GB)
Priority Data:
0201735.8 25.01.2002 GB
0201736.6 25.01.2002 GB
Title (EN) DNA DOSAGE FORMS
(FR) FORMES POSOLOGIQUES D'ADN
Abstract: front page image
(EN)The present invention relates to DNA formulations suitable for ballistic delivery into the skin of the human body. In particular the present invention provides DNA formulations suitable for ballistic administration of DNA vaccines into the skin. The present invention provides a novel DNA pharmaceutical agent dosage form, having a dense core element which is coated with an amorphous solid reservoir medium containing the DNA pharmaceutical agent.
(FR)L'invention concerne des formulations d'ADN convenant à l'injection balistique dans la peau du corps humain. Cette invention concerne, plus particulièrement, la production de formulations d'ADN convenant à l'injection balistique de vaccins d'ADN dans la peau. La présente invention produit une nouvelle forme posologique d'agents pharmaceutiques d'ADN, comportant un élément central dense revêtu d'un milieu réservoir solide amorphe contenant l'agent pharmaceutique d'ADN.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)